TGTX

29.61

0.24% 0.07

Dopo l'orario di chiusura: 29.40 -0.21 -0.71%

Tg Therapeutics Inc (TGTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TGTX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$29.54

Aprire:

$29.57

Volume 24 ore:

4.29M

Relative Volume:

1.17

Capitalizzazione di mercato:

$4.61B

Reddito:

$264.79M

Utile/perdita netta:

$-14.36M

Rapporto P/E:

-105.75

EPS:

-0.28

Flusso di cassa netto:

$67.82M

1 W Prestazione:

-3.68%

1M Prestazione:

+27.03%

6M Prestazione:

+79.67%

1 anno Prestazione:

+145.32%

Intervallo 1D:

$28.59

$30.00

Intervallo di 1 settimana:

$28.59

$36.50

Portata 52W:

$11.86

$36.50

Tg Therapeutics Inc Stock (TGTX) Company Profile

Nome

Tg Therapeutics Inc

Settore

Healthcare (1196)

Industria

Biotechnology (683)

Telefono

(212) 554-4484

Indirizzo

2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY

Dipendente

264

Cinguettio

@TGTherapeutics

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

TGTX's Discussions on Twitter

Confronta TGTX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TGTX	29.61	4.61B	264.79M	-14.36M	67.82M	-0.28
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-08-02	Aggiornamento	Goldman	Sell → Neutral
2023-06-26	Ripresa	Jefferies	Buy
2022-05-20	Iniziato	BofA Securities	Underperform
2022-02-23	Reiterato	B. Riley Securities	Buy
2021-11-15	Downgrade	Goldman	Neutral → Sell
2021-04-20	Iniziato	Goldman	Neutral
2021-04-19	Reiterato	H.C. Wainwright	Buy
2020-09-01	Iniziato	JP Morgan	Overweight
2020-08-11	Reiterato	H.C. Wainwright	Buy
2020-06-05	Iniziato	Evercore ISI	Outperform
2020-01-17	Reiterato	H.C. Wainwright	Buy
2019-11-27	Ripresa	B. Riley FBR	Buy
2019-02-06	Ripresa	Jefferies	Buy
2018-09-25	Downgrade	Raymond James	Strong Buy → Outperform
2018-03-09	Reiterato	B. Riley FBR, Inc.	Buy
2017-12-01	Ripresa	B. Riley FBR, Inc.	Buy
2017-11-14	Ripresa	H.C. Wainwright	Buy
2017-04-25	Iniziato	Jefferies	Buy
2017-03-06	Reiterato	FBR & Co.	Outperform
2016-10-06	Ripresa	Brean Capital	Buy
2016-05-27	Iniziato	SunTrust	Buy
2015-12-01	Iniziato	FBR Capital	Outperform
2015-09-09	Iniziato	Raymond James	Strong Buy
2015-08-12	Ripresa	H.C. Wainwright	Buy
2015-06-19	Reiterato	Brean Capital	Buy
2014-12-11	Reiterato	ROTH Capital	Buy
2014-12-10	Reiterato	ROTH Capital	Buy

Mostra tutto

Tg Therapeutics Inc Borsa (TGTX) Ultime notizie

03:54 AM

State of New Jersey Common Pension Fund D Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

03:54 AM

Nov 15, 2024

When (TGTX) Moves Investors should Listen - Stock Traders Daily

Nov 15, 2024

Entropy Technologies LP Purchases Shares of 31,200 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 15, 2024

Principal Financial Group Inc. Raises Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 15, 2024

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Amalgamated Bank - MarketBeat

Nov 15, 2024

Nov 13, 2024

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Los Angeles Capital Management LLC - MarketBeat

Nov 13, 2024

Nov 12, 2024

Insider Sale: Director Laurence Charney Sells 25,000 Shares of T - GuruFocus.com

Nov 12, 2024

Insider Sale: Director Sagar Lonial Sells 5,000 Shares of TG The - GuruFocus.com

Nov 12, 2024

Nov 10, 2024

New York State Teachers Retirement System Invests $1 Million in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 10, 2024

Nov 09, 2024

Don't Ignore The Insider Selling In TG Therapeutics - Simply Wall St

Nov 09, 2024

Nov 08, 2024

TG Therapeutics stock hits 52-week high at $28.43 - Investing.com India

Nov 08, 2024

TG Therapeutics stock hits 52-week high at $28.43 By Investing.com - Investing.com Canada

Nov 08, 2024

Optimistic Investors Push TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Up 27% But Growth Is Lacking - Simply Wall St

Nov 07, 2024

TG Therapeutics, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance

Nov 07, 2024

FY2024 EPS Estimates for TG Therapeutics Lowered by Analyst - MarketBeat

Nov 07, 2024

Nov 06, 2024

HC Wainwright Boosts Earnings Estimates for TG Therapeutics - MarketBeat

Nov 06, 2024

Nov 05, 2024